Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 19Glioblastoma 18Breast Neoplasms 18Squamous Cell Carcinoma of Head and Neck 16Lung Neoplasms 12Rectal Neoplasms 11Oropharyngeal Neoplasms 11Neoplasms 9Head and Neck Neoplasms 9Glioma 8Astrocytoma 8Neoplasm Metastasis 7Sarcoma 6Esophageal Neoplasms 6Carcinoma, Squamous Cell 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Lymphoma, Follicular 5Hodgkin Disease 5Gliosarcoma 5Esophageal Squamous Cell Carcinoma 5Carcinoma 5Burkitt Lymphoma 5Brain Neoplasms 5Adenocarcinoma of Lung 5Adenocarcinoma Of Esophagus 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Nasopharyngeal Carcinoma 4

Interventions

Radiotherapy 3fludarabine 2Cyclophosphamide 2pembrolizumab 1olaparib 1envafolimab 1avelumab 1Sunitinib 1Radiotherapy, Adjuvant 1Nivolumab 1Etoposide 1Drug Therapy 1Cisplatin 1Chemoradiotherapy 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Thymoma × Radiotherapy × 90 days × Clear all
NCT06019468 2026-05-08

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Recruiting
25 enrolled
Thoracic

Thymoma

NCT02633514 2026-04-27

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Fudan University

Phase 3 Withdrawn
Thoracic

Thymoma

NCT06402708 2026-04-27

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Fudan University

Phase 3 Recruiting
172 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡